XML 21 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:    
Net earnings (loss) $ 269 $ (88)
Adjustments to reconcile net earnings to net cash provided by operating activities:    
Depreciation and amortization 167 134
Equity in earnings of unconsolidated affiliates (1) 0
(Gain) loss on sales of investments and other assets and asset impairments, net (25) 213
Interest credited/index credits to contractholder account balances 513 542
Change in market risk benefits, net (11) 60
Deferred policy acquisition costs and deferred sales inducements (311) (251)
Charges assessed to contractholders for mortality and admin (66) (58)
Non-cash lease costs 33 35
Operating lease payments (38) (39)
Distributions from unconsolidated affiliates, return on investment 19 36
Stock-based compensation cost 16 14
Change in NAV of limited partnerships, net (49) (57)
Change in valuation of derivatives, equity and preferred securities, net (254) (216)
Changes in assets and liabilities, net of effects from acquisitions:    
Change in insurance recoverable (22) (79)
Change in future policy benefits 505 224
Change in funds withheld from reinsurers 940 1,124
Net decrease in trade receivables 8 45
Net decrease in reserve for title claim losses (24) (19)
Net change in income taxes 33 (28)
Net change in other assets and other liabilities (111) (174)
Net cash provided by operating activities 1,591 1,418
Cash flows from investing activities:    
Proceeds from sales, calls and maturities of investment securities 1,783 1,091
Additions to property and equipment, capitalized software and title plants (35) (34)
Purchases of investment securities (3,819) (4,077)
Net proceeds from sales and maturities of short-term investment securities 1,473 1,249
Additions to notes receivable (3) (4)
Collections of notes receivable 25 0
Acquisitions and dispositions (284) (273)
Additional investments in unconsolidated affiliates (272) (327)
Distributions from unconsolidated affiliates, return of investment 36 90
Net cash used in investing activities (1,096) (2,285)
Cash flows from financing activities:    
Borrowings 7 500
Debt costs/equity issuance additions (5) (10)
F&G Credit Agreement repayments, net 0 (35)
Dividends paid (130) (122)
Subsidiary dividends paid to non-controlling interest shareholders (7) (7)
Exercise of stock options 1 0
Additional investment in consolidated subsidiary (7) (20)
Net change in secured trust deposits (38) (61)
Payment of contingent consideration for prior period acquisitions (5) (2)
Contractholder account deposits 1,929 2,115
Contractholder account withdrawals (1,483) (950)
Purchases of treasury stock 0 (6)
Cash remitted for withholding taxes on share-based compensation (7) 0
Net cash provided by financing activities 255 1,402
Net increase in cash and cash equivalents 750 535
Cash and cash equivalents at beginning of period 2,767 2,286
Cash and cash equivalents at end of period $ 3,517 $ 2,821